Critical Diagnostics Release: Milestone Tenth Patent Issued for Cardiac Biomarker ST2

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics announced today that the United States Patent and Trademark Office issued a patent in connection with its ST2 assay covering “Methods for Treatment of Cardiovascular Disease.”

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC